|
93 Companies |
|
118 Products |
|
118 Products |
|
88 Mechanisms of Action |
|
3 Trials |
|
1622 News |
|
| «12345678910111213...3233» |
- || Enrollment change, Trial initiation date, Trial primary completion date: Capsule Endoscopy for Hemorrhage in the Emergency Room (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=100, Not yet recruiting, Sponsor: George Washington University
N=50 --> 100 | Initiation date: Mar 2011 --> Mar 2017 | Trial primary completion date: Jun 2017 --> Mar 2018
- Trial termination, Surgery, Bariatric surgery: Bariatric Surgery and Guided Self-help for Binge Eating Disorder (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=150, Terminated, Sponsor: Imperial College London
N=50 --> 100 | Initiation date: Mar 2011 --> Mar 2017 | Trial primary completion date: Jun 2017 --> Mar 2018 Recruiting --> Terminated; New evidence came to light to indicate that study was no longer relevant
- dexlansoprazole / Generic mfg.
Phase classification: Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn (clinicaltrials.gov) - Dec 19, 2016
P1, N=40, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Terminated; New evidence came to light to indicate that study was no longer relevant Phase classification: P4 --> P1
- Trial completion, Enrollment change: Anorexia Nervosa Genetics Initiative (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=22445, Completed, Sponsor: University of North Carolina, Chapel Hill
Phase classification: P4 --> P1 Recruiting --> Completed | N=13000 --> 22445
- Remicade (infliximab) / J&J
Trial primary completion date: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) (clinicaltrials.gov) - Dec 7, 2016
P3, N=67, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Recruiting --> Completed | N=13000 --> 22445 Trial primary completion date: Oct 2008 --> Feb 2006
- Trial primary completion date: STIMOREX: rTMS and Body Shape Perception (clinicaltrials.gov) - Dec 7, 2016
P=N/A, N=54, Recruiting, Sponsor: University Hospital, Rouen
Trial primary completion date: Oct 2008 --> Feb 2006 Trial primary completion date: Nov 2016 --> Mar 2018
- | Remicade (infliximab) / J&J
Trial completion: Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) (clinicaltrials.gov) - Dec 6, 2016
P3, N=67, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Trial primary completion date: Nov 2016 --> Mar 2018 Active, not recruiting --> Completed
- loperamide / Generic mfg., azithromycin / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=384, Terminated, Sponsor: Uniformed Services University of the Health Sciences
N=510 --> 384 | Recruiting --> Terminated | Trial primary completion date: May 2015 --> Mar 2016; AWD arm was completed. ADF diarrhea arm was unable to fill completely and there are no funds remaining to continue recruiting/enrolling.
- |||| aprepitant oral / Generic mfg.
Trial primary completion date, CINV: Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED) (clinicaltrials.gov) - Nov 23, 2016
P3, N=820, Completed, Sponsor: Merck Sharp & Dohme Corp.
ADF diarrhea arm was unable to fill completely and there are no funds remaining to continue recruiting/enrolling. Trial primary completion date: Feb 2004 --> Dec 2004
- Enrollment change, Trial termination: Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease (clinicaltrials.gov) - Nov 23, 2016
P=N/A, N=110, Terminated, Sponsor: Rutgers, The State University of New Jersey
Trial primary completion date: Feb 2004 --> Dec 2004 N=290 --> 110 | Suspended --> Terminated; Lack of recruitment
- Trial primary completion date: TreCogAM: Cognitive Remediation Therapy in Anorexia Nervosa (clinicaltrials.gov) - Nov 17, 2016
P=N/A, N=120, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
N=290 --> 110 | Suspended --> Terminated; Lack of recruitment Trial primary completion date: Oct 2016 --> Jun 2016
- |||| Resolor (prucalopride) / J&J, Takeda
Trial completion, Combination therapy: Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation (clinicaltrials.gov) - Nov 9, 2016
P4, N=280, Completed, Sponsor: Xian-Janssen Pharmaceutical Ltd.
Trial primary completion date: Oct 2016 --> Jun 2016 Recruiting --> Completed
- Trial completion: Lcr35 for Children With Functional Constipation (clinicaltrials.gov) - Nov 8, 2016
P4, N=94, Completed, Sponsor: Medical University of Warsaw
Recruiting --> Completed Recruiting --> Completed
- ||||||| Hydexor (promethazine/hydrocodone/acetaminophen) / Daiichi Sankyo, Charleston Labs
Trial completion, Enrollment change: Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain (clinicaltrials.gov) - Nov 3, 2016
P3, N=460, Completed, Sponsor: Charleston Laboratories, Inc
Recruiting --> Completed Recruiting --> Completed | N=810 --> 460
- hydromorphone hydrochloride / Generic mfg.
Trial primary completion date, Surgery: Nausea in Patients Receiving Hydromorphone vs Oxycodone After Total Hip Replacement Surgery (clinicaltrials.gov) - Oct 31, 2016
P4, N=200, Active, not recruiting, Sponsor: University Health Network, Toronto
Recruiting --> Completed | N=810 --> 460 Trial primary completion date: May 2015 --> Jun 2017
- Trial primary completion date: The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa (clinicaltrials.gov) - Oct 27, 2016
P2, N=23, Active, not recruiting, Sponsor: Massachusetts General Hospital
Trial primary completion date: May 2015 --> Jun 2017 Trial primary completion date: Sep 2016 --> Dec 2016
- Trial completion, Enrollment change: Urinary Markers for Unilateral Kidney Obstruction (clinicaltrials.gov) - Oct 26, 2016
P=N/A, N=53, Completed, Sponsor: Carmel Medical Center
Trial primary completion date: Sep 2016 --> Dec 2016 Recruiting --> Completed | N=100 --> 53
- | Trial completion: IRB 2003-551: UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer (clinicaltrials.gov) - Oct 20, 2016
P2, N=180, Completed, Sponsor: University of Michigan Cancer Center
Recruiting --> Completed | N=100 --> 53 Recruiting --> Completed
- |||| aprepitant oral / Generic mfg.
Trial completion: A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219) (clinicaltrials.gov) - Oct 18, 2016
P2b, N=229, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Neural Links Between OCD and Anorexia (clinicaltrials.gov) - Oct 17, 2016
P=N/A, N=45, Recruiting, Sponsor: Stanford University
Active, not recruiting --> Completed Trial primary completion date: Aug 2016 --> Dec 2016
- Trial primary completion date: TreCogAM: Cognitive Remediation Therapy in Anorexia Nervosa (clinicaltrials.gov) - Oct 11, 2016
P=N/A, N=120, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: Feb 2016 --> Oct 2016
- aprepitant oral / Generic mfg.
Enrollment change, Trial termination: Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents (clinicaltrials.gov) - Sep 30, 2016
P2, N=4, Terminated, Sponsor: The Hospital for Sick Children
Trial primary completion date: Feb 2016 --> Oct 2016 N=22 --> 4 | Recruiting --> Terminated; lack of eligible participants to enrol
- Trial completion, Enrollment change: Characteristics and Importance of Physical Activity in Women With Anorexia Nervosa (clinicaltrials.gov) - Sep 23, 2016
P=N/A, N=147, Completed, Sponsor: New York State Psychiatric Institute
N=22 --> 4 | Recruiting --> Terminated; lack of eligible participants to enrol Active, not recruiting --> Completed | N=80 --> 147
- olanzapine / Generic mfg.
Enrollment closed: Olanzapine Versus Placebo for Outpatients With Anorexia Nervosa (clinicaltrials.gov) - Sep 23, 2016
P=N/A, N=152, Active, not recruiting, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed | N=80 --> 147 Recruiting --> Active, not recruiting
- ||| aprepitant oral / Generic mfg.
Enrollment closed: A Study to Evaluate Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Children (MK-0869-219) (clinicaltrials.gov) - Sep 21, 2016
P2b, N=260, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | imipramine / Generic mfg.
Enrollment change: The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia (clinicaltrials.gov) - Sep 16, 2016
P3, N=107, Completed, Sponsor: Chinese University of Hong Kong
Recruiting --> Active, not recruiting N=184 --> 107
- Trial primary completion date, HEOR: Quality of Life And Psychological Symptoms In Children With Cyclic Vomiting Syndrome (CVS) (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=75, Active, not recruiting, Sponsor: Medical College of Wisconsin
N=184 --> 107 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial primary completion date, HEOR: Quality of Life (QOL), Coping and Psychological Symptoms in Children and Adolescents With Cyclic Vomiting Syndrome (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=120, Active, not recruiting, Sponsor: Medical College of Wisconsin
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion, Trial primary completion date: AcuGraph and Digestive Symptoms (clinicaltrials.gov) - Sep 15, 2016
P=N/A, N=30, Completed, Sponsor: Logan College of Chiropractic
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Mar 2009 --> Mar 2010 | Recruiting --> Completed
- dexamethasone injection / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Dexamethasone for Post-cesarean Delivery Pain (clinicaltrials.gov) - Sep 15, 2016
P4, N=48, Completed, Sponsor: Duke University
Trial primary completion date: Mar 2009 --> Mar 2010 | Recruiting --> Completed Recruiting --> Completed | N=104 --> 48 | Trial primary completion date: Dec 2016 --> Jun 2016
- Trial completion: Effect of Propofol on Internal Anal Sphincter Pressure During ARM (clinicaltrials.gov) - Sep 15, 2016
P=N/A, N=20, Completed, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | N=104 --> 48 | Trial primary completion date: Dec 2016 --> Jun 2016 Recruiting --> Completed
- Trial primary completion date: FAKT: Treatment of Eating Disorders by Physical Activity and Nutrition Counseling (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=128, Recruiting, Sponsor: Norwegian School of Sport Sciences
Recruiting --> Completed Trial primary completion date: Dec 2016 --> Jun 2017
- Trial completion: HAP-AM: Characteristics of Intensity and Dependence to Physical Activity in Anorexia Nervosa (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=300, Completed, Sponsor: Institut Mutualiste Montsouris
Trial primary completion date: Dec 2016 --> Jun 2017 Recruiting --> Completed
- Trial completion: Acupuncture Treatment for Gastroparesis: a Pilot Study (clinicaltrials.gov) - Sep 2, 2016
P1/2, N=20, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed Recruiting --> Completed
- Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Trial primary completion date: Efficacy of Rifaximin in Preventing Campylobacteriosis (clinicaltrials.gov) - Sep 1, 2016
P2/3, N=28, Active, not recruiting, Sponsor: Johns Hopkins Bloomberg School of Public Health
Recruiting --> Completed Trial primary completion date: Jun 2016 --> Dec 2016
- || Biomarker, Enrollment closed, Trial primary completion date, Head-to-Head: CACATU: Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD (clinicaltrials.gov) - Aug 30, 2016
P=N/A, N=355, Active, not recruiting, Sponsor: University Medical Center Groningen
Trial primary completion date: Jun 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Mar 2017
- Trial completion, Enrollment change, Trial primary completion date: Cognitive Processes Study in Obese Women With and Without Eating Disorders (clinicaltrials.gov) - Aug 29, 2016
P=N/A, N=108, Completed, Sponsor: Hospices Civils de Lyon
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Mar 2017 Recruiting --> Completed | N=90 --> 108 | Trial primary completion date: Jul 2017 --> Jun 2015
- Trial completion, Trial primary completion date: Treatment for Young Adults With Anorexia Nervosa (clinicaltrials.gov) - Aug 26, 2016
P1/2, N=30, Completed, Sponsor: Temple University
Recruiting --> Completed | N=90 --> 108 | Trial primary completion date: Jul 2017 --> Jun 2015 Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Apr 2016
- | thalidomide / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Efficacy of Thalidomide in Preventing Chemotherapy-induced Delayed Nausea and Vomiting (clinicaltrials.gov) - Aug 24, 2016
P3, N=642, Completed, Sponsor: China Medical University, China
Recruiting --> Completed | Trial primary completion date: Mar 2014 --> Apr 2016 Recruiting --> Completed | N=820 --> 642 | Trial primary completion date: Jul 2015 --> Jul 2016
- Trial completion, Trial primary completion date, Surgery, Metastases: Decreasing Narcotics in Advanced Pelvic Surgery (clinicaltrials.gov) - Aug 17, 2016
P4, N=138, Completed, Sponsor: Hartford Hospital
Recruiting --> Completed | N=820 --> 642 | Trial primary completion date: Jul 2015 --> Jul 2016 Recruiting --> Completed | Trial primary completion date: May 2016 --> Jul 2015
- Trial completion: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (clinicaltrials.gov) - Aug 15, 2016
P2, N=7, Completed, Sponsor: Alliance for Clinical Trials in Oncology
Recruiting --> Completed | Trial primary completion date: May 2016 --> Jul 2015 Terminated --> Completed
- Enrollment closed: Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia (clinicaltrials.gov) - Aug 13, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: Stanford University
Terminated --> Completed Recruiting --> Active, not recruiting
- |||| Aemcolo (rifamycin SV MMX) / Cosmo Pharma, RedHill, Dr Falk
Trial primary completion date: ERASE: Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea (clinicaltrials.gov) - Aug 9, 2016
P3, N=776, Active, not recruiting, Sponsor: Dr. Falk Pharma GmbH
Recruiting --> Active, not recruiting Trial primary completion date: Apr 2016 --> Sep 2016
- omeprazole / Generic mfg.
Enrollment change, Trial termination: Use of Maytenus Ilicifolia in the Treatment of Dyspepsia (clinicaltrials.gov) - Jul 26, 2016
P2, N=4, Terminated, Sponsor: Casa Espirita Terra de Ismael
Trial primary completion date: Apr 2016 --> Sep 2016 N=140 --> 4 | Suspended --> Terminated; Lack of adherence and huge loss of follow up.
- || ondansetron / Generic mfg., temozolomide / Generic mfg.
Trial primary completion date, Combination therapy, CINV: Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide (clinicaltrials.gov) - Jul 26, 2016
P2, N=136, Recruiting, Sponsor: Katy Peters
N=140 --> 4 | Suspended --> Terminated; Lack of adherence and huge loss of follow up. Trial primary completion date: Jun 2016 --> Jun 2017
- Enrollment change, Trial withdrawal: Modified Functional Magnetic Stimulation Treatment for Constipation Improvement (clinicaltrials.gov) - Jul 24, 2016
P=N/A, N=0, Withdrawn, Sponsor: Taipei Medical University WanFang Hospital
Trial primary completion date: Jun 2016 --> Jun 2017 N=140 --> 0 | Terminated --> Withdrawn
- ||||||| doxylamine/pyridoxine / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Pre-emptive Treatment of Severe Nausea and Vomiting of Pregnancy (clinicaltrials.gov) - Jul 24, 2016
P3, N=76, Completed, Sponsor: The Hospital for Sick Children
N=140 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed | N=150 --> 76 | Trial primary completion date: Feb 2015 --> Jun 2012
- Trial primary completion date: Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea (clinicaltrials.gov) - Jul 23, 2016
P=N/A, N=50, Active, not recruiting, Sponsor: Medical College of Wisconsin
Active, not recruiting --> Completed | N=150 --> 76 | Trial primary completion date: Feb 2015 --> Jun 2012 Trial primary completion date: Jun 2016 --> Jun 2018
- Trial completion, Enrollment change, Trial primary completion date: Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa (clinicaltrials.gov) - Jul 21, 2016
P2, N=50, Completed, Sponsor: Boston University
Trial primary completion date: Jun 2016 --> Jun 2018 Recruiting --> Completed | N=74 --> 50 | Trial primary completion date: May 2011 --> Dec 2012
- Trial initiation date, Trial suspension, Trial primary completion date: Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease (clinicaltrials.gov) - Jul 19, 2016
P=N/A, N=290, Suspended, Sponsor: Rutgers, The State University of New Jersey
Recruiting --> Completed | N=74 --> 50 | Trial primary completion date: May 2011 --> Dec 2012 Initiation date: Apr 2013 --> Nov 2015 | Recruiting --> Suspended | Trial primary completion date: Dec 2016 --> Jul 2016